Cases of COVID-19 infection are increasing steadily throughout the world, including in the country. More than 90 thousand new cases of infection have been filed in the last 24 hours. With this, the country has become the second most effective country due to COVID-19 infection leaving Brazil behind. However, to get rid of this, vaccine trials are going on all over the world, including India. Here is a good news about the indigenous 'Covaxin' developed by Bharat Biotech.

According to media reports, drug regulation has allowed the second round trial of this vaccine. It is believed that its trial can begin from 7 September. According to a statement by the Director General of Health Services, there was a video conferencing between health experts on 3 September, in which India Biotech was discussed about the vaccine, and it was approved to send it in the second round of the trial.

According to the same reports, the vaccine will be tested on 380 volunteers in the second round of the trial, and after the dose is given, they will be kept under medical care for the next four days to see if there are any side effects of the vaccine. Not happening According to reports, in the first phase of this vaccine of Bharat Biotech has been tried in many different parts of the country. Dr. E. Vecant Rao, Chief Investigator of Trial at the Institute of Medical Science, says that no side-effects of this vaccine have been seen in the first round of trials. This is a major achievement of India.

Also Read:

Gold and silver prices are rising, know today's rate

Miscreants beat man to death as he sent his daughter to relative's place to save her from them

Nitish Kumar lashed out at the opposition, says ' Bihar has electricity no lantern needed'

IPL 2020 under threat,After CSK, member of this team test positive for corona